Copper and boron as examples of dietary trace elements important in bone development and disease

Current Opinion in Orthopaedics

Volumn 9, Issue 5, 1998, Pages 28-36

  Hunt, Curtiss D ^a  

^a GRAND FORKS HUMAN NUTRITION RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BORON; CHELATING AGENT; COPPER; DEFEROXAMINE; EDETIC ACID; TRACE ELEMENT; VITAMIN D; ZINC;

ARTICLE; BONE ATROPHY; BONE DEVELOPMENT; BONE DISEASE; BONE GROWTH; CLINICAL FEATURE; COPPER DEFICIENCY; DIETARY INTAKE; DIFFERENTIAL DIAGNOSIS; DRUG EFFECT; FRACTURE; HUMAN; OSTEOPENIA; PRIORITY JOURNAL; VASCULAR DISEASE;

EID: 0032428345     PISSN: 10419918     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001433-199810000-00006     Document Type: Article

References (71)

1. Schrauzer GN: The discovery of the essential trace elements: an outline of the history of biological trace element research. In Biochemistry of the Essential Ultratrace Elements. Edited by Frieden E. Plenum. New York; 1984:17-31.
2. Frieden E: A survey of the essential biochemical elements. In Biochemistry of the Essential Ultratrace Elements. Edited by Frieden E. Plenum. New York; 1984:1-15.
3. Solomons NW: Biochemical, metabolic, and clinical role of copper in human nutrition. J Am Coll Nutr 1985, 4:83-105.
4. Prohaska JR, Bailey WR, Lear PM: Copper deficiency alters rat peptidylglycine alpha-amidating monooxygenase activity. J Nutr 1995, 125:1447-1454.
5. Gacheru SN, Trackman PC, Shah MA, O'Gara CY, Spacciapoli P, Greenaway FT, Kagan HM: Structural and catalytic properties of copper in lysyl oxidase. J Biol Chem 1990, 265:19022-19027.
6. National Research Council: Recommended Dietary Allowances, edn 10. Washington, DC: National Academy Press; 1989.
7. Pennington JAT, Young BE, Wilson DB: Nutritional elements in U.S. diets: results from the Total Diet Study, 1982-86. J Am Diet Assoc 1989, 89:659-664.
8. Klevay LM, Medeiros DM: Deliberations and evaluations of the approaches, endpoints and paradigms for dietary recommendations about copper. J Nutr 1996, 126(suppl):2419S-2426S.
9. Shaw JCL: Copper deficiency and non-accidental injury. Arch Dis Child 1988, 63:448-455.
10. Cordano A, Graham GG: Copper deficiency complicating severe chronic intestinal malabsorption. Pediatrics 1966, 38:596-604.
11. Graham GG, Cordano A: Copper depletion and deficiency in the malnourished infant. Johns Hopkins Med J 1969, 124:139-150.
12. Velin P, Dupont D, Daoud A: Nutritional copper deficiency: apropos of a case. Ann Pediatr (Paris) 1989, 36:269-274.
13. Grünebaum M, Horodniceanu C, Steinherz R: The radiographie manifestations of bone changes in copper deficiency, Pediatr Radiol 1980, 9:101-104.
14. Jonas J, Burns J, Abel EW, Cresswell MJ, Strain JJ, Paterson CR: Impaired mechanical strength of bone in experimental copper deficiency. Ann Nutr Metab 1993, 37:245-252.
15. Conlan D, Korula R, Tallentire D: Serum copper levels in elderly patients with femoral-neck fractures. Age Ageing 1990, 19:212-214.
16. Eaton-Evans J, Mcllrath EM, Jackson WE, McCartney H, Strain JJ: Copper supplementation and the maintenance of bone mineral density in middle-aged women. J Trace Elem Exp Med 1997, 9:87-94. In Northern Ireland, apparently healthy women (45 to 56 years of age) supplemented with copper (3 mg/d for 2 years) maintained, whereas age-matched placebo control subjects lost, VTBMD.
17. Strause L, Saltman P, Smith KT, Bracker M, Andon MB: Spinal bone loss in postmenopausal women supplemented with calcium and trace minerals. J Nutr 1994, 124:1060-1064.
18. Ashkenazi A, Levin S, Djaldetti M, Fishel E, Benvenisti D: The syndrome of neonatal copper deficiency, Pediatrics 1973, 52:525-533.
19. Prohaska JR, Bailey WR: Persistent regional changes in brain copper, cuproenzymes and catecholamines following perinatal copper deficiency in mice. J Nutr 1993, 123:1226-1234.
20. Tamura H, Hirose S, Watanabe O, Arai K, Murakawa M, Matsumura O, Isoda K: Anemia and neutropenia due to copper deficiency in enterai nutrition. J Parenter Enterai Nutr 1994, 18:185-189.
21. Dunlap WM, Watson III J, Hume DM: Anemia and neutropenia caused by copper deficiency. Ann Intern Med 1974, 80:470-476.
22. Dubick MA, Hunter GC, Casey SM, Keen CL: Aortic ascorbic acid, trace elements, and Superoxide dismutase activity in human aneurysmal and occlusive disease. Proc Soc Exp Biol Med 1987, 184:138-143.
23. Burns J, Forsyth JS, Paterson CR: Assessment of copper status in preterm infants: limited value of assays of erythrocyte copper concentration and superoxide dismutase activity. J Clin Biochem Nutr 1991, 11:69-77.
24. Dauncey MJ, Shaw JCL, Urman J: The absorption and retention of magnesium, zinc and copper by low birth weight infants fed pasteurized human breast milk. Pediatr Res 1977, 2:991-997.
25. Naveh Y, Hazani A, Berant M: Copper deficiency with cow's milk diet. Pediatrics 1981, 68:397-400.
26. Castillo-Duran C, Fisberg M, Valenzuela A, Egana JI, Uauy R: Controlled trial of copper supplementation during the recovery from marasmus. Am J Clin Nutr 1983, 37:898-903.
27. Goel R, Misra PK, Seth TD: Study of plasma copper in protein-energy malnutrition. Indian Pediatr 1980, 17:139-150.
28. Kiilholma P, Grönroos M, Näntö V, Paul R: Pregnancy and delivery in Ehlers-Danlos syndrome. Acta Obstet Gynecol Scand 1984, 63:437-439.
29. Danks DM, Campbell PE, Walker-Smith J, Stevens BJ, Gillespie JM, Bloomfield J, Turner B: Menkes' kinky-hair syndrome. Lancet 1972, 1:1100-1103.
30. Fiske DN, McCoy HEI, Kitchens CS: Zinc-induced sideroblastic anemia: report of a case, review of the literature, and description of the hematologie syndrome. Am J Hematol 1994, 46:147-150.
31. Prasad AS, Brewer GJ, Schoomaker EB, Rabbani P: Hypocupremia induced by zinc therapy in adults. JAMA 1978, 240:2166-2168.
32. Summerfield AL, Steinberg FU, Gonzalez JG: Morphologic findings in bone marrow precursor cells in zinc-induced copper deficiency anemia. Am J Clin Pathol 1992, 97:665-668.
33. Hoffbrand AV, Wonke B: Iron chelation therapy. J Intern Med 1997, 740(suppl):37-41.
34. Zafeiriou DI, Kousi AA, Tsantali CT, Konotopoulos EE, Augoustidou-Savvopoulou PA, Tsoubaris PD, Athanasiou MA: Neurophysiologic evaluation of long-term desferrioxamine therapy in beta-thalassemia patients. Pediatr Neural 1998, 18:420-424. Lengthy deferoxamine therapy to reduce iron overload in patients with ß-thalassemia was associated with lower serum copper concentrations.
35. Kontoghiorghes GJ: Comparative efficacy and toxicity of desferrioxamine, deferiprone and other iron and aluminum chelating drugs. Toxicol Lett 1995, 80:1-18.
36. Pall H, Blake DR, Winyard P, Lunec J, Williams A, Good PA, et al.: Ocular toxicity of desferrioxamine-an example of copper promoted auto-oxidative damage? Br J Ophthalmol 1989, 73:42-47.
37. Chisolm JJ Jr: Evaluation of the potential role of chelation therapy in treatment of low to moderate lead exposures. Environ Health Perspect 1990, 89:67-74.
38. Guldager B, Jorgensen PJ, Grandjean P: Metal excretion and magnesium retension in patients with intermittent claudication treated with intravenous disodium EDTA. Clin Chem 1996, 42:1938-1942.
39. Grier MT, Meyers DG: So much writing, so little science: a review of 37 years of literature on edetate sodium chelation therapy. Ann Pharmacother 1993, 27:1504-1509.
40. Guldager B, Brixen KT, Jorgensen SJ, Nielsen HK, Mosekilde L, Jelnes R: Effects of intravenous EDTA treatment on serum parathyroid hormone (1-84) and biochemical markers of bone turnover. Dan Med Bull 1993, 40:627-630.
41. Aaseth J, Haugen M, Forre O: Rheumatoid arthritis and metal compounds: perspectives on the role of oxygen radical detoxification. Analyst 1998, 123:3-6.
42. McQuaid A, Lamand M, Mason J: The interactions of penicillamine with copper in vivo and the effect on hepatic metallothionein levels and copper/zinc distribution: the implications for Wilson's disease and arthritis therapy. J Lab Clin Med 1992, 119:744-750.
43. Mizuta E, Kuno S: Effect of D-penicillamine on pharmacokinetics of levodopa in Parkinson's disease. Clin Neuropharmacol 1993, 16:448-450.
44. Hottinger AF, Fine EG, Gurney ME, Zurn AD, Aebischer P: The copper chelator d-penicillamine delays onset of disease and extends survival in a transgenic mouse model of familial amyotrophic lateral sclerosis. Eur J Neurosci 1997, 9:1548-1551.
45. Milanino R, Frigo A, Bambara LM, Marrella M, Moretti U, Pasqualicchio M, Biasi D, Gasperini R, Mainenti L, Velo GP: Copper and zinc status in rheumatoid arthritis: studies of plasma, erythrocytes, and urine, and their relationship to disease activity markers and pharmacological treatment. Clin Exp Rheumatol 1993, 11:271-281.
46. Yeowell HN, Marshall MK, Walker LC, Ha V, Pinnell SR: Regulation of lysyl oxidase mRNA in dermal fibroblasts from normal donors and patients with inherited connective tissue disorders. Arch Biochem Biophys 1994, 308:299-305.
47. Kozak SF, Inderlied CB, Hsu HY, Heller KB, Sadun AA: The role of copper on ethambutol's antimicrobial action and implications for ethambutol-induced optic neuropathy. Diagn Microbiol Infect Dis 1998, 30:83-87. Evidence from this in vitro study suggested that the principal side effect (an optic neuropathy) of the antimycobacterial agent ethambutol that may be caused by the inadvertent chelation of copper may be alleviated by concurrent administration of copper.
48. Hunt CD: The biochemical effects of physiological amounts of dietary boron. J Trace Elem Exp Med 1996, 9:185-213.
49. Fort DJ, Propst TL, Schetter T, Stover EL, Strong PL, Murray FJ: Adverse developmental and reproductive effects of insufficient boron in Xenopus: building a case for nutritional essentiality [abstract]. FASEB J 1998, 12:A205. First report of boron essentiality in frogs as evidenced by abnormal development of the gut, craniofacial region, and eye; visceral edema; and kinking of the tail musculature and notochord in specimens deprived of dietary boron.
50. Eckhert CD: Boron stimulated embryonic growth in rainbow trout is not a result of antimicrobial action [abstract]. FASEB J 1998, 12:A205. First report of boron essentiality in fish as evidenced by a reduced rate of embryonic growth in specimens deprived of dietary boron.
51. Hunt CD, Stoecker BJ: Deliberations and evaluations of the approaches, endpoints and paradigms for boron, chromium and fluoride dietary recommendations. J Nutr 1996, 126(suppl):2441S-2451S.
52. Bai Y, Hunt CD: Dietary boron enhances efficacy of cholecalciferol in broiler chicks. J Trace Elem Exp Med 1996, 9:117-132.
53. 3 nutriture on indices of energy substrate utilization and mineral metabolism in the chick. J Bone Miner Res 1994, 9:171-181.
54. Hunt CD: Dietary boron modified the effects of magnesium and molybdenum on mineral metabolism in the cholecalciferol-deficient chick. Biol Trace Elem Res 1989, 22:201-220.
55. King N, Odom TW, Sampson HW, Yersin AG: The effect of in ovo boron supplementation on bone mineralization of the vitamin D-deficient chicken embryo. Biol Trace Elem Res 1991, 31:223-233.
56. Shah SA, Vohora SB: Boron enhances anti-arthritic effects of garlic oil. Fitoterapia 1990, 61:121-126.
57. Fracp RLT, Rennie GC, Newnham RE: Boron and arthritis: the results of a double-blind pilot study. J Nutr Med 1990, 1:127-132.
58. Badin J, Levesque H: Précipitation rapide du facteur rhumatoïde dans une solution d'acide borique et titrage parl'agglutination des hématies humaines sensibilisées. Rev Rhum 1961, 28:101-107.
59. Bai Y, Hunt CD: Dietary boron alleviates adjuvant-induced arthritis (AIA) in rats [abstract]. FASEB J 1995, 9:A576.
60. Bai Y, Hunt CD: Dietary boron (B) increases serum antibody concentrations in rats immunized with heat-killed Mycobacterium Tuberculosis (MT) [abstract]. FASEB J 1996, 10.A819.
61. Svensson S, Hammarstrom SG, Kabat EA: The effect of borate on polysaccharide-protein and antigen-antibody reactions. Immunochemistry 1970, 7:413-422.
62. Bakken NA: Dietary boron modifies the effects of vitamin D nutriture on energy metabolism and bone morphology in the chick [MS thesis]. Grand Forks, ND: University of North Dakota; 1995.
63. 3-deficient chick. In Trace Element Metabolism in Man and Animals, edn 8. Edited by Anke M, Meissner D, Mills C. Gersdorf, Germany: Verlag Media Touristik; 1993:714-718.
64. Hunt CD, Nielsen FH: Interaction between boron and cholecalciferol in the chick. In Trace Element Metabolism in Man and Animals, edn 4. Edited by Gawthorne J, White C. Canberra: Australian Academy of Science; 1981:597-600.
65. Nielsen FH, Mullen LM, Gallagher SK. Effect of boron depletion and repletion on blood indicators of calcium status in humans fed a magnesium-low diet. J Trace Elem Exp Med 1990, 3:45-54.
66. Nielsen FH, Gallagher SK, Johnson LK, Nielsen EJ: Boron enhances and mimics some effects of estrogen therapy in postmenopausal women. J Trace Elem Exp Med 1992, 5:237-246.
67. Tietz NW: Textbook of clinical chemistry. Philadelphia: WB Saunders; 1986.
68. Lacey DL, Huffer WE: Studies on the pathogenesis of avian rickets: I. Changes in epiphyseal and metaphyseal vessels in hypocalcemic and hypophosphatemic rickets. Am J Pathol 1982, 109:288-301.
69. Hegsted M, Keenan MJ, Siver F, Wozniak P: Effect of boron on vitamin D deficient rats. Biol Trace Elem Res 1991, 28:243-256.
70. Hunt CD, Herbel JL, Nielsen FH: Metabolic response of postmenopausal women to supplemental dietary boron and aluminum during usual and low magnesium intake: boron, calcium, and magnesium absorption and retention and blood mineral concentrations. Am J Clin Nutr 1997, 65:803-813. First report of boron in humans housed in a metabolic research unit and conuming a typical mixed Western diet of known boron content over a period time (6 moths).
71. Meacham SL, Taper LJ, Volpe SL. Effect of boron supplementation on blood and urinary calcium, magnesium, and phosphorus, and urinary boron in athletic and sedentary women. Am J Clin Nutr